Head & Neck Pathology

metrics 2024

Fostering Excellence in Head & Neck Research

Introduction

Head & Neck Pathology is a leading journal dedicated to advancing the study of pathologies affecting the head and neck region, published by Springer. With an ISSN of 1936-055X and E-ISSN of 1936-0568, this journal serves as a vital resource for the dissemination of research in oncology, otorhinolaryngology, and pathology, achieving impressive rankings of Q2 in Oncology and Q1 in both Otorhinolaryngology and Pathology & Forensic Medicine in 2023. Since its inception in 2007, Head & Neck Pathology has continued to provide a platform for innovative research findings, case studies, and reviews, fostering a deeper understanding of head and neck diseases. The journal's commitment to excellence is reflected in its rigorous peer-review process and accessibility through various academic platforms. Researchers, clinicians, and students will find valuable insights and knowledge that can enhance clinical practice and improve patient outcomes in the dynamic field of head and neck pathology.

Metrics 2024

SCIMAGO Journal Rank0.89
Journal Impact Factor3.20
Journal Impact Factor (5 years)2.80
H-Index67
Journal IF Without Self3.20
Eigen Factor0.00
Normal Eigen Factor0.85
Influence0.72
Immediacy Index0.40
Cited Half Life5.30
Citing Half Life8.90
JCI0.95
Total Documents1534
WOS Total Citations3430
SCIMAGO Total Citations9648
SCIMAGO SELF Citations794
Scopus Journal Rank0.89
Cites / Document (2 Years)3.45
Cites / Document (3 Years)3.36
Cites / Document (4 Years)3.32

Metrics History

Rank 2024

IF (Web Of Science)

PATHOLOGY
Rank 25/88
Percentile 72.20
Quartile Q2

JCI (Web Of Science)

PATHOLOGY
Rank 28/88
Percentile 68.18
Quartile Q2

Quartile History

Similar Journals

AURIS NASUS LARYNX

Advancing knowledge in otorhinolaryngology and surgery.
Publisher: ELSEVIER SCI LTDISSN: 0385-8146Frequency: 4 issues/year

AURIS NASUS LARYNX, published by Elsevier Science Ltd, is a leading peer-reviewed journal specializing in the fields of otorhinolaryngology, surgery, and general medicine. Since its inception in 1974, this esteemed journal has been committed to disseminating high-quality research and innovative findings pertinent to the diagnosis, treatment, and management of ear, nose, and throat diseases. With an impressive 2023 impact factor reflected in its Q2 quartile rankings in both Medicine (miscellaneous) and Otorhinolaryngology, as well as its strong position in Surgery, AURIS NASUS LARYNX is regarded highly among researchers and practitioners. The journal is accessible through a subscription model, ensuring that essential knowledge remains within reach for both clinical and academic pursuits. The continuous evolution of its content promises to stay at the forefront of medical advancements, making it an invaluable resource for scholars, clinicians, and students striving for excellence in the medical field.

Ocular Oncology and Pathology

Empowering the Fight Against Ocular Diseases
Publisher: KARGERISSN: 2296-4681Frequency: 6 issues/year

Ocular Oncology and Pathology is a distinguished journal dedicated to the multifaceted study of ocular diseases, particularly focusing on oncology and pathology. Published by KARGER, a reputable publisher based in Switzerland, this journal serves as a vital resource for researchers, clinicians, and students in the fields of ophthalmology, pathology, and oncology. With an ISSN of 2296-4681 and an E-ISSN of 2296-4657, the journal has established itself as a significant contributor to the literature, achieving a commendable ranking of 55th out of 139 in the General Nursing category within Scopus, placing it in the 60th percentile. Now converging its expertise until 2024, Ocular Oncology and Pathology aims to publish high-quality, peer-reviewed research articles that advance the understanding of ocular neoplasms and their pathological features. The journal’s commitment to open access promotes the dissemination of vital scientific knowledge, ensuring worldwide accessibility to high-impact research, making it an essential platform for the academic community.

Current Opinion in Otolaryngology & Head and Neck Surgery

Elevating standards in head and neck surgical practice.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1068-9508Frequency: 6 issues/year

Current Opinion in Otolaryngology & Head and Neck Surgery is a distinguished journal published by Lippincott Williams & Wilkins, aimed at advancing the field of otolaryngology. With an ISSN of 1068-9508 and an E-ISSN of 1531-6998, this journal delivers insightful reviews and critical analyses of contemporary research developments in otolaryngology and head and neck surgery. The journal holds a commendable Q2 ranking in both the fields of Medicine (miscellaneous) and Otorhinolaryngology, as well as in Surgery, according to the 2023 Category Quartiles. Its Scopus rankings further underscore its credibility, positioned at #199 in Medicine Surgery and #54 in Otorhinolaryngology. Established since 1995 and set to continue through 2024, Current Opinion in Otolaryngology & Head and Neck Surgery serves as a crucial resource for researchers, clinicians, and students seeking to stay informed on the latest trends and innovations in the field. While not an open-access journal, it offers a subscription model that grants access to high-quality, peer-reviewed content essential for professional development and academic excellence.

LARYNGOSCOPE

Elevating Clinical Practices for Better Patient Outcomes
Publisher: WILEYISSN: 0023-852XFrequency: 12 issues/year

LARYNGOSCOPE, published by Wiley, is a premier journal in the field of Otorhinolaryngology, boasting an impressive impact factor and ranked #8 out of 123 in its category, placing it in the 93rd percentile among its peers. Since its inception in 1896, the journal has served as a vital platform for disseminating high-quality research, innovative clinical practices, and advancements in the study of ear, nose, and throat diseases. The journal is committed to providing comprehensive coverage of original research, case studies, and reviews that shape the future of Otorhinolaryngology. With a notable Q1 category ranking in 2023, it remains at the forefront of medical publications, making it an essential resource for researchers, health professionals, and students who seek to stay abreast of the latest developments in the field. Although not an Open Access journal, it provides valuable insights that contribute to the understanding and treatment of complex disorders within otolaryngology. The journal’s dedication to excellence ensures its readers receive cutting-edge information that is critical for advancing their work and enhancing patient care.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY

Transforming insights into clinical practice.
Publisher: WILEYISSN: 0194-5998Frequency: 12 issues/year

OTOLARYNGOLOGY-HEAD AND NECK SURGERY, published by Wiley, stands as a premier journal in the fields of otorhinolaryngology and surgery, boasting an impressive impact ranking in the 95th percentile among its peers. With an ISSN of 0194-5998 and E-ISSN 1097-6817, this journal has been a cornerstone for researchers and clinicians since its inception in 1978, continuing its valuable contributions to 2024. Notably, it holds a Q1 category ranking in both Otorhinolaryngology and Surgery, exemplifying its influence and the high caliber of research it publishes. As it garners significant attention in the scientific community, researchers are encouraged to delve into its articles for comprehensive insights into advanced surgical techniques and emerging trends in head and neck medicine. Access to its extensive repository of research is available through traditional subscription models, allowing professionals and students alike to benefit from the wealth of knowledge at their fingertips.

Annals of Diagnostic Pathology

Shaping the Future of Pathology, One Study at a Time.
Publisher: ELSEVIER SCIENCE INCISSN: 1092-9134Frequency: 6 issues/year

Annals of Diagnostic Pathology, published by Elsevier Science Inc, is a pivotal journal in the field of diagnostic pathology that has significantly contributed to the advancement of medical science since its inception in 1997. With an ISSN of 1092-9134 and E-ISSN of 1532-8198, this esteemed journal is positioned within the Q2 category in both Medicine (miscellaneous) and Pathology and Forensic Medicine, reflecting its high-quality research contributions, showcased by its ranking at #73 out of 208 in Scopus for the latter category. The journal's scope encompasses various aspects of diagnostic pathology, from innovative techniques to critical reviews of pathologic findings, making it an essential resource for researchers, medical professionals, and students dedicated to enhancing diagnostic accuracy and patient care. Although it does not currently offer open access options, its wide readership and impactful publications continue to influence clinical practices and research agendas. With a convergence period extending to 2024, Annals of Diagnostic Pathology remains a leading platform for disseminating valuable knowledge in this dynamic field.

Journal of Pathology and Translational Medicine

Championing Open Access in Pathology Research
Publisher: KOREAN SOC PATHOLOGISTSISSN: 2383-7837Frequency: 6 issues/year

The Journal of Pathology and Translational Medicine, published by the Korean Society of Pathologists, is a distinguished peer-reviewed Open Access journal that has been at the forefront of advancing the field of pathology and histology since its inception in 1985. With an established ISSN of 2383-7837 and an E-ISSN of 2383-7845, the journal serves as a vital platform for disseminating high-quality research, fostering collaboration among professionals and offering valuable insights into both clinical applications and theoretical advancements. Recognized for its influence in the field, it holds a commendable Q2 ranking in both Histology and Pathology & Forensic Medicine categories in 2023, and ranks #52/208 in Scopus for Medicine – Pathology and Forensic Medicine, demonstrating its impact and reach within the academic community. Located in South Korea at 1209 Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, this journal not only caters to researchers and professionals but also supports students striving to deepen their understanding of pathology. Join the growing body of knowledge and stay updated with the latest findings in this essential field of study through the journal's open access format, promoting worldwide accessibility and engagement.

Oral & Maxillofacial Pathology Journal

Transforming Clinical Practices in Oral Health
Publisher: KAIRALI SOC ORAL & MAXILLOFACIAL PATHOLOGISTSISSN: 0976-1225Frequency: 2 issues/year

Oral & Maxillofacial Pathology Journal is a prominent peer-reviewed publication dedicated to advancing the field of oral and maxillofacial pathology. Published by the KAIRALI SOCIETY OF ORAL & MAXILLOFACIAL PATHOLOGISTS, this journal aims to provide a platform for sharing innovative research, clinical practices, and new techniques related to the diagnosis and management of oral diseases. With a commitment to open access, it ensures that valuable knowledge reaches a global audience of researchers, dental professionals, and students alike. Although specific impact metrics such as the HIndex and Scopus ranking are not listed, the journal is regarded as an essential resource for those involved in the oral health community. It plays a crucial role in fostering collaboration and disseminating cutting-edge advancements that can enhance patient care and clinical outcomes in oral pathology. For professionals looking to stay ahead in this dynamic field, Oral & Maxillofacial Pathology Journal serves as an indispensable tool for both foundational learning and advanced research.

Head & Face Medicine

Fostering collaboration in the realms of Dentistry, Otorhinolaryngology, and Neurology.
Publisher: BMCISSN: Frequency: 1 issue/year

Head & Face Medicine, published by BMC, serves as a vital open-access platform for advancing research and clinical practices in the fields of Dentistry, Otorhinolaryngology, and Neurology. Since its inception in 2005, this journal has nurtured contributions that span a diverse range of topics, making significant strides in understanding complex head and facial conditions. With an impressive categorization in the 2023 Journal Rankings, where it is recognized in Q1 for both Dentistry and Otorhinolaryngology, as well as Q2 for Neurology, it holds a prestigious position in the academic community, fostering innovative ideas and collaborations. The journal's commitment to free access ensures widespread availability of groundbreaking research, promoting knowledge dissemination among researchers, healthcare professionals, and students alike. Located in the United Kingdom and continuously prioritizing rigorous peer review, Head & Face Medicine is essential for anyone seeking to stay at the forefront of medical advancements concerning head and facial health.

ENDOCRINE PATHOLOGY

Innovative Insights into Endocrine Disorders
Publisher: HUMANA PRESS INCISSN: 1046-3976Frequency: 4 issues/year

ENDOCRINE PATHOLOGY is a premier journal published by HUMANA PRESS INC, dedicated to advancing the understanding of endocrine disorders through innovative research and clinical practices. With an impressive impact factor and consistently ranked in the Q1 quartile across multiple categories such as Endocrinology, Diabetes and Metabolism, as well as Pathology and Forensic Medicine, this journal serves as a pivotal resource for researchers and professionals in the field. The journal covers a broad spectrum of topics related to endocrine pathology, providing insights into mechanisms, diagnostics, and therapeutics that inform both clinical and laboratory practices. Although it does not offer open access, its rigorous peer-review process ensures the dissemination of high-quality, impactful research that shapes clinical strategies and enhances patient care. With distribution spanning from its inception in 1990 to 2024, ENDOCRINE PATHOLOGY stands at the forefront of endocrine research, making it an essential read for anyone involved in the study and treatment of endocrine disorders.